| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |